Global Peptide Therapeutics Market is expected to reach US$ XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 9.5% during the forecast period.
Global Peptide Therapeutics Market Overview:
Peptides are known for their high selectivity and efficacy while still being relatively safe and well-tolerated. As a result, peptides are receiving more attention in pharmaceutical research and development (R&D), with approximately 140 peptide therapeutics currently undergoing clinical trials.
Global Peptide Therapeutics Market Dynamics:
The use of peptide molecules in the development of the COVID-19 vaccine is expected to increase, which will boost the market growth.
Vaxil announced the creation of a vaccine based on a proprietary signal peptide (SP) discovered using a bioinformatics tool in 2020. This strategy allows for the development of targeted therapies against cancer or infectious disease pathogens by using signal peptide domains on critical proteins.
Government funding for the use of peptides in the production of the COVID-19 vaccine is expected to provide a potential incentive for peptide adoption, which will potentially stimulate the growth of the peptide therapeutics market.
Growing cases of metabolic and infectious disorders are expected to stimulate market growth during the forecast period. The Centers for Disease Control and Prevention (CDC) states that about 34.2 million people in the United States were diagnosed with diabetes in 2020. Furthermore, the prevalence of diabetes continues to rise in comparison to previous decades, according to the same research. Diseases such as brain disorders and cancers are becoming more prevalent, resulting in higher healthcare costs.
Countries that are experiencing economic difficulties are more likely to implement cost-effective and reliable peptide therapeutics in order to reduce their healthcare costs. The American Cancer Society’s study suggests that there will be 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in the United States in 2020. The public awareness of peptide therapeutics and the implementation of favorable reimbursement policies by governments around the world are likely to influence consumers and doctors to seek out cost-effective therapeutic peptides in order to introduce experimental drugs for the treatment of serious disorders.
The global peptide therapeutics market is expected to be hampered by natural peptides' poor chemical and physical stability, as well as their limited circulating plasma half-life. However, since peptide drugs are administered by injection, low oral availability, and poor penetration of the intestinal mucosa are expected to limit market growth in the near future.
The development of new peptides are expected to provide lucrative growth opportunities for market players. CohBar, Inc., in 2019 announced new preclinical evidence that demonstrated the therapeutic potential of a novel CohBar peptide in a preclinical model of Idiopathic Pulmonary Fibrosis (IPF).
The report has profiled eighteen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.
Global Peptide Therapeutics Market Segment Analysis:
The Global Peptide Therapeutics Market is segmented on the basis of Type, Application and Route of Administration.
Based on Type, the branded segment held the largest market share in 2019. The segment growth is attributed to factors such as major pharmaceutical companies growing investments in R&D for the production of new drugs and high prescription rates. Generics, on the other hand, are expected to rise at a healthy rate over the forecast period. The use of generics is expected to be accelerated by rising healthcare spending and increased healthcare spending by the federal government.
Based on the Application, the cancer segment is expected to dominate the global market during the forecast period. The main factors driving this segment's dominance are an increase in the global incidence of cancer and an increase in the prescription of peptide therapeutics for cancer care. The growing demand for effective and fast-acting therapeutics is expected to boost growth even further.
The growing demand for effective and fast-acting therapeutics is expected to boost growth even further. Patients and healthcare practitioners are becoming more mindful of the negative effects of chemotherapy and radiation therapy, which is leading to a greater emphasis on alternative therapeutics such as peptide-based medications.
To know about the Research Methodology :- Request Free Sample Report
Global Peptide Therapeutics Market Regional Insights:
North America is expected to dominate the global market.
The market in North America is anticipated to dominate as a result of factors such as increased understanding of peptide therapeutics, the growing need for diagnostics in cancer and other diseases, and the expanding biotechnology industry. Increased government and industry spending on research and development is also expected to help peptide therapeutics maintain their supremacy in the coming years. Another factor such as the well-established biopharmaceutical and pharmaceutical industry in this region is a major driver of growth.
Asia Pacific is expected to witness lucrative growth during the forecast period.
Over the forecast period, the Asia-Pacific peptide therapeutics market is expected to expand significantly, owing to rising biotech companies and government healthcare spending, as well as the rising prevalence of cancer and nervous system disorders. These factors are anticipated to impact positively on the market growth in APAC.
The report also helps in understanding the Global Peptide Therapeutics Market dynamics, structure by analyzing the market segments and project the Global Peptide Therapeutics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Peptide Therapeutics Market make the report investor’s guide.
Global Peptide Therapeutics Market Key Developments:
• Bioniz Therapeutics Inc., a clinical-stage biopharmaceutical company developing first-in-class peptide treatments for immuno-inflammatory diseases, was acquired by Almirall, S.A. in January 2020.
• Zealand Pharma A/S, a Copenhagen-based biotechnology company focusing on the discovery and production of novel peptide-based medicines, announced the acquisition of Encycle Therapeutics, Inc., a private Toronto-based biotech company with a unique platform technology that enables the rapid synthesis of macrocyclic peptides with enhanced drug-like properties, in October 2019.
For more information of visit:https://www.maximizemarketresearch.com/market-report/global-peptide-therapeutics-market/101400/
Global Peptide Therapeutics Market Scope: Inquire before buying
Global Peptide Therapeutics Market, by Region
• North America
• Europe
• South America
• MEA
• APAC
Global Peptide Therapeutics Market Key Players
• Eli Lilly and Company
• Amgen Inc.
• TEVA PHARMACEUTICAL INDUSTRIES LTD
• Polypeptide Group
• EVER Pharma GmbH
• Bristol-Myers Squibb Company
• Novo Nordisk A/S
• Sanofi
• AstraZeneca PLC
• Glaxosmithkline PLC
• Pfizer, Inc.
• Takeda Pharmaceutical Company Limited
• Lonza Inc
• Novartis AG
• Bachem Holding AG
• CordenPharma International
• Ipsen S.A
• Merck & Co., Inc
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
